Pyrexia of Unknown Origin (PUO): Causes and Management
Definition and Initial Diagnostic Workup
PUO is defined as fever ≥38.3°C lasting at least three weeks with no cause identified after three days of inpatient investigation or three outpatient visits. 1
Immediate Actions
- Obtain blood cultures from peripheral vein and all indwelling catheters before starting any antimicrobials 2
- Perform complete blood count with differential to assess for neutropenia (ANC <0.5 × 10^9/L indicates severe neutropenia requiring immediate broad-spectrum antibiotics) 2
- Order chest imaging (X-ray or CT) for respiratory symptoms or persistent fever 2
Major Causes of PUO
The causes fall into four broad categories, with specific entities to actively investigate 3, 1:
Infectious Causes
- Tuberculosis remains a leading cause, particularly in HIV-positive patients, and can affect any organ system 4
- Bacterial infections including occult abscesses, endocarditis, and osteomyelitis 3
- Viral infections (HIV, CMV, EBV) 3
- Fungal infections in immunocompromised patients 2
Inflammatory/Autoimmune Causes
- Inflammatory bowel disease (Crohn's disease) can present as PUO with minimal gastrointestinal symptoms in young adults 5
- Connective tissue diseases (systemic lupus erythematosus, rheumatoid arthritis, vasculitis) 3
- Sarcoidosis 4
Neoplastic Causes
Miscellaneous Causes
- Drug-induced fever (BRAF inhibitors commonly cause pyrexia 2-4 weeks after initiation) 6
- Thromboembolic disease 3
Systematic Investigation Strategy
History Taking Priorities
Take a detailed medication history to identify drug-induced causes (immunosuppressants, BRAF inhibitors, chemotherapy agents) 6
Document environmental exposures at home, work, and frequently visited places: specifically ask about mold, birds, down feathers, animals, metal dusts, wood dust, livestock, and recent occupational changes 6
Laboratory Testing Sequence
- Blood cultures (multiple sets from different sites)
- CBC with differential and absolute neutrophil count
- Comprehensive metabolic panel
- Inflammatory markers (ESR, CRP)
- Urinalysis and urine culture
Second-tier serological testing if connective tissue disease suspected: 6
- ANA, RF, anti-CCP antibodies
- Anti-dsDNA, complement levels (C3, C4)
- Creatine phosphokinase, myoglobin, aldolase
- Antisynthetase antibodies (Jo-1)
- Anti-Scl-70/topoisomerase-1 for scleroderma
- Anti-SSA/Ro and anti-SSB/La for Sjögren syndrome
- ANCA for vasculitis
Advanced Imaging
For prolonged unexplained fever beyond initial workup, FDG-PET/CT should be performed as it has high sensitivity and specificity for detecting infections, inflammatory processes, and occult malignancies 2, 4
High-resolution chest CT is indicated if fungal infection suspected, looking for nodules with haloes or ground-glass changes 2, 7
Management Algorithm Based on Clinical Scenario
Severe Neutropenia (ANC <0.5 × 10^9/L)
Initiate broad-spectrum antibacterial therapy immediately without waiting for culture results 2, 7
Do not delay antimicrobial therapy while awaiting diagnostic workup 2, 7
Persistent Fever >4-6 Days Despite Antibiotics
Consider initiating empiric antifungal therapy (voriconazole or liposomal amphotericin B for suspected aspergillosis) 2, 7
Perform bronchoalveolar lavage if infiltrates found on imaging 2
Low-Risk Patients with Recovered Neutrophil Counts
For patients with ANC ≥0.5 × 10^9/L at 48 hours who are afebrile and asymptomatic, consider switching to oral antibiotics or discontinuing aminoglycosides 2
Avoid unnecessary antibiotic continuation in recovered, afebrile patients 2
Stable Patients with No Diagnosis After Extensive Workup
In stable patients without progressive disease, careful clinical observation for new symptoms is preferred over empiric antimicrobial courses 8
Up to 50% of PUO cases remain undiagnosed despite adequate investigation, but this cohort has a good prognosis 3
Critical Pitfalls to Avoid
Signs and symptoms of infection may be minimal or absent in neutropenic patients, especially those on corticosteroids—maintain high suspicion even with low-grade fever 7
BRAF inhibitor-induced pyrexia typically occurs 2-4 weeks after starting therapy and requires drug discontinuation plus antipyretics (acetaminophen/NSAIDs), not antibiotics 6
Consider colonoscopy if abdominal CT shows bowel wall thickening, as inflammatory bowel disease can present as PUO with minimal GI symptoms 5
Thrombocytopenia may preclude invasive diagnostic procedures—assess risk-benefit and consider platelet transfusion before procedures 7